Torren Management’s Inspire Medical Systems INSP Stock Holding History

Torren Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3	Closed	-$277	–	1204
2025 Q4	$277	Buy	+3	New	+$287	﹤0.01%	1394

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Torren Management's INSP Position: Q1 2026 in Review

Torren Management sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 3 shares — an estimated $277 sold.

Torren Management first reported a position in INSP in Q4 2025 and held it in 1 quarter. The position peaked at $277 in Q4 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

Torren Management reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
Torren Management sold 3 Inspire Medical Systems shares in Q1 2026, an estimated $277.
Torren Management first reported a position in Inspire Medical Systems in Q4 2025 and held it in 1 quarter.
Torren Management's Inspire Medical Systems position peaked at $277 in Q4 2025.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.